<DOC>
	<DOCNO>NCT00958451</DOCNO>
	<brief_summary>This open label , single center , randomize , active comparator control study , compare effect vitamin D replacement use oral ergocalciferol versus paricalcitol parathyroid hormone ( PTH ) level patient stage 3 4 CKD vitamin D deficiency insufficiency . The purpose study determine two approach successful .</brief_summary>
	<brief_title>Vitamin D Deficiency Chronic Kidney Disease ( CKD ) Patients</brief_title>
	<detailed_description>This study enroll chronic kidney disease patient , stage 3 4 , low serum vitamin D level define K DOQI Guidelines . Patients randomize receive oral daily ergocalciferol paricalcitol . A total 80 patient enrol , 40 cholecalciferol group 40 paricalcitol group . Outcomes assessed proportion patient achieve pre-defined change baseline absolute change baseline value . Baseline value determine average two consecutive measurement variables interest prior randomization .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>1 . Male female chronic kidney disease patient least 18 year age . 2 . Patients able willing provide write informed consent HIPAA Authorization . 3 . Chronic kidney disease stage 3 4 . 4 . Plasma intactPTH level 75pg/ml . 5 . Serum 25 OHD level 30ng/ml . 6 . Negative pregnancy test unless 2 year postmenopausal document tubal ligation total hysterectomy . 7 . Patients need Vitamin analogue preparation 4 week prior screen . 1 . Women breast feeding , pregnant , capable become pregnant , participate acceptable form birth control . 2 . Patients currently participate clinical trial another investigational drug device receive investigational drug device within 30 day enrollment study . 3 . Major surgery within one month prior enrollment plan surgery patient study ( dialysis vascular access surgery ) . 4 . Patients malignancy unless receive curative treatment disease free 2 year . 5 . Patients medical status PI decide would preclude participation . 6 . Patients hemodialysis peritoneal dialysis . 7 . Patients functional renal transplant . 8 . Patients allergy study drug . 9 . Patients acute renal failure past 12 week . 10 . Patients clinically significant gastrointestinal liver disease . 11 . Patients active granulomatous disease . 12 . Patients urine calcium : creatinine ratio 0.2 . 13 . Patients receive vitamin D analog , calcimimetics , biphosphonates within 4 week screen . Treatment one medicine study permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Calcium</keyword>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Chronic Kidney disease</keyword>
</DOC>